Welcome to MicroEpitope!

Increasing evidences have shown that both bacteria and viruses encode microbial antigens that are molecular mimics of tumour antigens. The burgeoning field of intratumoral microbiome research has been driven by advances in high-throughput detection technologies. Notably, mass spectrometry (MS) technology enables the direct identification of immune epitopes derived from microbiota, extending host immunopeptidome in cancer. Here, we proposed MicroEpitope for providing and visualizing the atlas of HLA-presented immune epitopes derived from cancer microbiome.